Scandinavian Journal of Rheumatology This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Comparing the safety and efficacy of nintedanib starting dose in patients with connective tissue disease-associated interstitial lung diseases
CONCLUSION: There was no evidence for a difference between the two groups in terms of discontinuation rates, efficacy, and safety. To provide further evidence, future studies using more precise dose-escalation protocols are warranted.PMID:38563202 | DOI:10.1080/03009742.2024.2327159 (Source: Scandinavian Journal of Rheumatology)
Source: Scandinavian Journal of Rheumatology - April 2, 2024 Category: Rheumatology Authors: M Ayano K Tsubouchi K Suzuki Y Kimoto Y Arinobu K Akashi T Horiuchi I Okamoto H Niiro Source Type: research

Van Neck-Odelberg disease in an elderly patient
Scand J Rheumatol. 2024 Apr 2:1-2. doi: 10.1080/03009742.2024.2330248. Online ahead of print.NO ABSTRACTPMID:38563192 | DOI:10.1080/03009742.2024.2330248 (Source: Scandinavian Journal of Rheumatology)
Source: Scandinavian Journal of Rheumatology - April 2, 2024 Category: Rheumatology Authors: X Wang W Feng Source Type: research

Efficacy of denosumab against osteoporosis determined using quantitative computed tomography in treatment-na ïve male patients with ankylosing spondylitis: case series of six patients
Scand J Rheumatol. 2024 Mar 26:1-3. doi: 10.1080/03009742.2024.2316960. Online ahead of print.NO ABSTRACTPMID:38529827 | DOI:10.1080/03009742.2024.2316960 (Source: Scandinavian Journal of Rheumatology)
Source: Scandinavian Journal of Rheumatology - March 26, 2024 Category: Rheumatology Authors: S H Kim S-H Lee R Song Source Type: research

Immunoglobulin G/immunoglobulin M autoantibody ratios in incomplete systemic lupus erythematosus
CONCLUSION: IgG anti-dsDNA, anti-Ro52, anti-Ro60, and IgM anti-dsDNA were elevated in iSLE and SLE patients, which was not apparent from the respective IgG/IgM ratios only. IgG/IgM autoantibody ratios remained relatively stable over up to 5 years in iSLE non-progressors and six patients who progressed to SLE.PMID:38505972 | DOI:10.1080/03009742.2024.2321700 (Source: Scandinavian Journal of Rheumatology)
Source: Scandinavian Journal of Rheumatology - March 20, 2024 Category: Rheumatology Authors: S Henning J Westra C Roozendaal G Haarsma-de Boer J J Fierro B Horvath H Bootsma K de Leeuw Source Type: research